Hourglass Capital, LLC Gilead Sciences, Inc. Transaction History

Hourglass Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $263,991 - $284,817	-3,900 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$71.28 - $78.92 $28,512 - $31,568	-400 Reduced 9.3%	3,900 $301,000
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $4.12 Million - $4.8 Million	-63,475 Reduced 93.66%	4,300 $305,000
Q1 2018 May 07, 2018	SELL	$72.84 - $88.8 $2.97 Million - $3.62 Million	-40,785 Reduced 37.57%	67,775 $5.11 Million
Q4 2017 Feb 08, 2018	SELL	$71.15 - $83.52 $124,156 - $145,742	-1,745 Reduced 1.58%	108,560 $7.78 Million

Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $7.95 Million - $9.43 Million	110,305	110,305 $8.94 Million

1,885

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $84.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Hourglass Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Hourglass Capital, LLC with notifications on news.